Robert S. Fletcher, who serves as Vice President and Chief Legal Officer at Stryker Corp (NYSE:SYK), conducted a notable sale of company stock on May 28, 2026. The transaction involved the disposition of 4,544 shares of the company's common stock, amounting to $1,394,409. The sales executed during this period saw per-share prices ranging between $304.225 and $310.22.
It is important to note that these share dispositions were carried out under the framework of a Rule 10b5-1 trading plan, which Mr. Fletcher established on February 26, 2026. The reported insider activity takes place against a backdrop of market data for Stryker. Currently, the company carries a market capitalization of $117.7 billion and is trading below its InvestingPro Fair Value, suggesting potential valuation discrepancies that could signal upside opportunity to investors.
From a historical stability perspective, the healthcare equipment giant has maintained dividend payments for 36 consecutive years, according to available data. Following these recent sales, Mr. Fletcher's direct holdings in Stryker common stock stand at 10,582 shares. Additionally, his indirect stake includes 183 shares held through a 401(k) plan.
The timing of the insider sale coincides with several key corporate announcements regarding Stryker’s recent financial performance and strategic updates. Specifically, Stryker Corporation released its Q1 2026 earnings report. This period was significantly impacted by a reported cyber incident, which affected the company's results.
During this quarter, Stryker missed analyst projections on both key metrics. The company posted an Earnings Per Share (EPS) of $2.60, falling short of the anticipated $2.98 per share. Furthermore, revenue reached $6 billion, compared to the expected figure of $6.34 billion.
Despite these setbacks in Q1 performance and the impact of the cyberattack, management provided reassurance by reaffirming its full guidance for the year 2026. In response to the challenges posed by the cyberincident, Argus adjusted its price target for Stryker shares, lowering it from $435 to $350, while concurrently maintaining a 'Buy' rating on the stock.
On the governance and shareholder front, the recent annual meeting saw all ten members of the board of directors re-elected. Furthermore, the board declared a quarterly dividend payment of $0.88 per share. This represents a 4.8% increase compared to the prior year's payout. The dividend is scheduled for distribution on July 31, 2026, payable to shareholders who own stock as of June 30, 2026.
Risks
- The company's Q1 performance was significantly impacted by a cyber incident, which caused it to miss analyst consensus on earnings and revenue.
- Argus lowered its price target for Stryker shares from $435 to $350 following the reported cyberattack impact.
More from Insider Trading
Risks
- The company's Q1 performance was significantly impacted by a cyber incident, which caused it to miss analyst consensus on earnings and revenue.
- Argus lowered its price target for Stryker shares from $435 to $350 following the reported cyberattack impact.